ArcticZymes Technologies Past Earnings Performance
Past criteria checks 3/6
ArcticZymes Technologies has been growing earnings at an average annual rate of 11.8%, while the Biotechs industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 13.1% per year. ArcticZymes Technologies's return on equity is 5.6%, and it has net margins of 14.8%.
Key information
11.8%
Earnings growth rate
11.5%
EPS growth rate
Biotechs Industry Growth | 11.5% |
Revenue growth rate | 13.1% |
Return on equity | 5.6% |
Net Margin | 14.8% |
Next Earnings Update | 22 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How ArcticZymes Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 118 | 18 | 63 | 0 |
31 Dec 23 | 120 | 19 | 61 | 0 |
30 Sep 23 | 119 | 18 | 59 | 0 |
30 Jun 23 | 118 | 14 | 63 | 0 |
31 Mar 23 | 120 | 17 | 63 | 0 |
31 Dec 22 | 138 | 33 | 61 | 0 |
30 Sep 22 | 150 | 47 | 59 | 0 |
30 Jun 22 | 147 | 52 | 52 | 0 |
31 Mar 22 | 139 | 48 | 52 | 0 |
31 Dec 21 | 131 | 46 | 48 | 0 |
30 Sep 21 | 114 | 68 | 45 | 0 |
30 Jun 21 | 108 | 67 | 43 | 0 |
31 Mar 21 | 120 | 84 | 37 | 0 |
31 Dec 20 | 98 | 74 | 35 | 0 |
30 Sep 20 | 64 | 43 | 27 | 0 |
30 Jun 20 | 68 | 37 | 29 | 0 |
31 Mar 20 | 88 | 8 | 46 | 0 |
31 Dec 19 | 49 | -1 | 34 | 0 |
30 Sep 19 | 80 | -9 | 49 | 0 |
30 Jun 19 | 79 | -10 | 47 | 0 |
31 Mar 19 | 73 | -13 | 47 | 0 |
31 Dec 18 | 73 | -14 | 46 | 0 |
30 Sep 18 | 70 | -20 | 49 | 0 |
30 Jun 18 | 63 | -27 | 50 | 0 |
31 Mar 18 | 69 | -27 | 51 | 0 |
31 Dec 17 | 73 | -25 | 52 | 0 |
30 Sep 17 | 74 | -26 | 59 | 0 |
30 Jun 17 | 80 | -24 | 58 | 0 |
31 Mar 17 | 79 | -21 | 57 | 0 |
31 Dec 16 | 79 | -20 | 57 | 0 |
30 Sep 16 | 78 | -20 | 53 | 0 |
30 Jun 16 | 72 | -19 | 51 | 0 |
31 Mar 16 | 66 | -18 | 49 | 0 |
31 Dec 15 | 59 | -17 | 47 | 0 |
30 Sep 15 | 55 | -15 | 42 | 0 |
30 Jun 15 | 48 | -16 | 41 | 0 |
31 Mar 15 | 46 | -18 | 39 | 0 |
31 Dec 14 | 38 | -22 | 38 | 0 |
30 Sep 14 | 34 | -23 | 38 | 0 |
30 Jun 14 | 31 | -21 | 37 | 0 |
31 Mar 14 | 26 | -24 | 37 | 0 |
31 Dec 13 | 28 | -23 | 38 | 0 |
30 Sep 13 | 29 | -23 | 33 | 0 |
Quality Earnings: 0DRV has high quality earnings.
Growing Profit Margin: 0DRV's current net profit margins (14.8%) are higher than last year (14.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0DRV has become profitable over the past 5 years, growing earnings by 11.8% per year.
Accelerating Growth: 0DRV's earnings growth over the past year (2.8%) is below its 5-year average (11.8% per year).
Earnings vs Industry: 0DRV earnings growth over the past year (2.8%) did not outperform the Biotechs industry 2.9%.
Return on Equity
High ROE: 0DRV's Return on Equity (5.6%) is considered low.